Myomo (MYO) Interest Expenses (2016 - 2025)
Myomo (MYO) posted Interest Expenses of $148296.0 for Q4 2025, down 94.79% on a QoQ basis from $2.8 million in Q3 2025, and up 14.41% year-over-year from $129615.0 in Q4 2024.
Myomo (MYO) Interest Expenses (2016 - 2025) Analysis & Trends
Myomo's Interest Expenses history runs 10 years deep, the most recent figure standing at $148296.0 for Q4 2025.
- Quarterly Interest Expenses rose 14.41% year-over-year to $148296.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $148296.0 (up 14.41% YoY) and the FY2025 annual result came in at $148296.0, down 99.12% from the prior year.
- Interest Expenses was $148296.0 for Q4 2025 at Myomo, down from $2.8 million in the prior quarter.
- Across five years, Interest Expenses topped out at $3.0 million in Q2 2025 and bottomed at $587.0 in Q4 2022.
- A 5-year average of $594914.2 and a median of $233232.5 in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses tumbled 97.47% — and 2023, when it jumped 39271.04%.
- Myomo's Interest Expenses stood at $23194.0 in 2021, then tumbled by 97.47% to $587.0 in 2022, then soared by 39271.04% to $231108.0 in 2023, then plunged by 43.92% to $129615.0 in 2024, then gained by 14.41% to $148296.0 in 2025.
- Business Quant data shows MYO's Interest Expenses at $148296.0 in Q4 2025, $2.8 million in Q3 2025, and $3.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 148,296.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 148,296.00 |
| Dec 31, 2025 | 148,296.00 |
| Sep 30, 2025 | 2.85 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 3.02 Mn |
| Jun 30, 2025 | 3.02 Mn |
| Mar 31, 2025 | 111,865.00 |
| Mar 31, 2025 | 111,865.00 |
| Dec 31, 2024 | 129,615.00 |
| Dec 31, 2024 | 129,615.00 |
| Sep 30, 2024 | 247,451.00 |
| Sep 30, 2024 | 247,451.00 |
| Jun 30, 2024 | 160,104.00 |
| Jun 30, 2024 | 160,104.00 |
| Mar 31, 2024 | 224,424.00 |
| Mar 31, 2024 | 224,424.00 |
| Dec 31, 2023 | 231,108.00 |
| Dec 31, 2023 | 231,108.00 |
| Sep 30, 2023 | 235,357.00 |
| Sep 30, 2023 | 235,357.00 |